Related Experiment Video
Updated: Jul 28, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Nursing care of patients receiving Campath
1seelkm@stlo.smhs.com
Abstract:
Monoclonal antibodies are focused therapies with unique infusion-related complications. Campath (alemtuzumab, Berlex Laboratories, Richmond, CA) is indicated for the treatment of refractory chronic lymphocytic leukemia and has a complicated administration schedule, severe infusion-related toxicity, and profound immunosuppressive capability. Ambulatory cancer care is challenging simply because of the complex nature of the disease. Management of complicated therapies, such as Campath, stretches resources and requires a coordinated effort by the healthcare team for successful patient outcomes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cardiac Catheterization IV: Nursing Management
Nephrotic Syndrome III : Nursing Management
Hemodialysis III: Nursing Management
Kidney Transplant III: Nursing Management
Chronic Kidney Disease IV: Nursing Management